McGill JB, Agarwal R, Anker SD, Bakris GL, et al. Effects of finerenone in persons with CKD and T2D are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline. Diabetes Obes Metab 2023 Feb 1. doi: 10.1111/dom.14999.
PMID: 36722675